Françoise Howe (@francoiseshowe) 's Twitter Profile
Françoise Howe

@francoiseshowe

Coordinating research into cancer precision prevention and early detection at the University of Oxford. Former yeast molecular geneticist. Views my own.

ID: 860083787266482176

calendar_today04-05-2017 10:48:49

176 Tweet

143 Followers

101 Following

Françoise Howe (@francoiseshowe) 's Twitter Profile Photo

Special lecture from Sir Richard Peto Oxford Population Health (OxPop) (summarised by Sir John Burn) acknowledging the 70th anniversary of the discovery of the link between smoking and cancer in Oxford #PrevConf24 Oxford Cancer

Special lecture from Sir Richard Peto <a href="/Oxford_NDPH/">Oxford Population Health (OxPop)</a> (summarised by Sir John Burn) acknowledging the 70th anniversary of the discovery of the link between smoking and cancer in Oxford

#PrevConf24 <a href="/OxfordCancer/">Oxford Cancer</a>
Françoise Howe (@francoiseshowe) 's Twitter Profile Photo

Oxford’s Sarah Blagden introducing precision prevention trials in people at higher risk of cancer, including the MILI trial for those with Li Fraumeni Syndrome #PrevConf24 Oxford Cancer OCTO Oxford OxfordOncology

Oxford’s <a href="/sarah_blagden/">Sarah Blagden</a> introducing precision prevention trials in people at higher risk of cancer, including the MILI trial for those with Li Fraumeni Syndrome

#PrevConf24

<a href="/OxfordCancer/">Oxford Cancer</a> <a href="/OCTO_Oxford/">OCTO Oxford</a> <a href="/OxfordOncology/">OxfordOncology</a>
Science and Innovation at Cancer Research UK (@crukresearch) 's Twitter Profile Photo

🎙️"Are population-based prevention studies fast enough?" Sarah Blagden says we need to rethink how we are designing studies and highlights OCTO Oxford - Oxford first UK centre to specialise in precision prevention & early detections trials. University of Oxford | Sharon A. Savage, M.D. |

🎙️"Are population-based prevention studies fast enough?" <a href="/sarah_blagden/">Sarah Blagden</a> says we need to rethink how we are designing studies and highlights <a href="/OCTO_Oxford/">OCTO Oxford</a> - Oxford first UK centre to specialise in precision prevention &amp; early detections trials. 

<a href="/UniofOxford/">University of Oxford</a> | <a href="/SharonSavageMD/">Sharon A. Savage, M.D.</a> |
Françoise Howe (@francoiseshowe) 's Twitter Profile Photo

And huge congratulations to Holly Eggington for being the best early career researcher poster prize winner for the mechanistic theme!   A very worthy recipient of one of this year’s OxCODE travel awards! Oxford Cancer #PrevConf24

Françoise Howe (@francoiseshowe) 's Twitter Profile Photo

That’s 2 out of 2 success for this year’s OxCODE travel award winners in the #PrevConf24 poster prizes (guess we chose our candidates well 😊)! Congratulations to both Zhe Huang Oxford Population Health (OxPop) and Holly Eggington Centre for Human Genetics Oxford Cancer

Helen White (@helenwhite100) 's Twitter Profile Photo

Exciting progress for those of us with Lynch syndrome! As 1 of 4 in the PPI group contributing to this research, it’s brilliant that the researchers have listened to us. A potential vaccine that could prevent not just bowel cancer, but also womb cancer! 🙌#LynchSyndrome #PPI

Science and Innovation at Cancer Research UK (@crukresearch) 's Twitter Profile Photo

David Church & Simon Leedham will use a Biology to Prevention Award to work on a precision prevention vaccination strategy for Lynch syndrome. They will define candidate frameshift peptides and determine mechanisms of immune escape. Simon Leedham | University of Oxford | #CRUKFunded

Science and Innovation at Cancer Research UK (@crukresearch) 's Twitter Profile Photo

After winning #PrevConf24 poster prize, Zhe Huang (University of Oxford) talked to us about his work on investigating the proteomic profiles of #ProstateCancer, his trip to Boston and the story behind his early career. Read more👇

Oxford Cancer (@oxfordcancer) 's Twitter Profile Photo

'Thanks to this funding, our research can take a big step forward towards a viable vaccine for ovarian cancer.' Professor Ahmed Ahmed MRC WIMM comments on new funding from Science and Innovation at Cancer Research UK to create the world’s first vaccine to prevent #OvarianCancer. 👇 cancer.ox.ac.uk/news/funding-t…

'Thanks to this funding, our research can take a big step forward towards a viable vaccine for ovarian cancer.'

Professor Ahmed Ahmed <a href="/MRC_WIMM/">MRC WIMM</a> comments on new funding from <a href="/CRUKresearch/">Science and Innovation at Cancer Research UK</a> to create the world’s first vaccine to prevent #OvarianCancer. 👇

cancer.ox.ac.uk/news/funding-t…
Cancer Research UK (@cr_uk) 's Twitter Profile Photo

#InTheNews We’ve awarded researchers at the University of Oxford up to £600,000 to create the world’s first vaccine to prevent ovarian cancer. OvarianVax is a vaccine that will teach the immune system to recognise and attack the earliest stages of ovarian cancer.

Oxford Cancer (@oxfordcancer) 's Twitter Profile Photo

Oxford Centre for Cancer Early Detection and Prevention Symposium 10-11th December, Oxford Keynote speakers: Victor Velculescu Johns Hopkins University, Sam Janes UCL Faculty of Medical Sciences, Molly Stevens Kavli Institute for Nanoscience Discovery, Oxford and Dr Georgia Black Wolfson Institute of Population Health Abstracts due: 8th Nov Register ⬇️ eventbrite.co.uk/e/oxford-centr…

Canary Center at Stanford (@canarycenter) 's Twitter Profile Photo

💡 Jens Rittscher (Jens Rittscher) is leveraging AI to analyze endoscopy images for Barrett’s esophagus. 🤖🔬 His lab focuses on automated quantification for data-driven phenotyping, with exciting potential to extend into spatial transcriptomics and thicker tissue

💡 Jens Rittscher (<a href="/JensRittscher/">Jens Rittscher</a>) is leveraging AI to analyze endoscopy images for Barrett’s esophagus. 🤖🔬

His lab focuses on automated quantification for data-driven phenotyping, with exciting potential to extend into spatial transcriptomics and thicker tissue
Genomics England (@genomicsengland) 's Twitter Profile Photo

Our latest episode explores research that identified 250+ genes that play a crucial role in bowel cancer, offering hope for prevention, screening and targeted treatments. Tune in as our guests discuss the findings and their impact 🎙️ Listen here: ow.ly/qpMu50Ua4hY

Our latest episode explores research that identified 250+ genes that play a crucial role in bowel cancer, offering hope for prevention, screening and targeted treatments. Tune in as our guests discuss the findings and their impact 🎙️

Listen here: ow.ly/qpMu50Ua4hY
Science and Innovation at Cancer Research UK (@crukresearch) 's Twitter Profile Photo

🚀The wait is over: registration is open for our second annual Cancer Prevention Research Conference! Get your ticket & join us in London to discuss the latest concepts in cancer prevention research. Register today: bit.ly/3OAqjLS #PrevConf25 | American Cancer Society

🚀The wait is over: registration is open for our second annual Cancer Prevention Research Conference! Get your ticket &amp; join us in London to discuss the latest concepts in cancer prevention research.

Register today: bit.ly/3OAqjLS

#PrevConf25 | <a href="/AmericanCancer/">American Cancer Society</a>
Françoise Howe (@francoiseshowe) 's Twitter Profile Photo

It’s hard to believe that OxCODE has been going for 5 years already! We’re celebrating with a 2-day symposium of talks, panel discussions, posters and networking. Looking forward to some excellent science! #oxcode24 Oxford Cancer

It’s hard to believe that OxCODE has been going for 5 years already!

We’re celebrating with a 2-day symposium of talks, panel discussions, posters and networking. Looking forward to some excellent science!

#oxcode24
<a href="/OxfordCancer/">Oxford Cancer</a>
Oxford Cancer (@oxfordcancer) 's Twitter Profile Photo

How to get your research funded? We heard insights from our panel: Talisia Quallo @CRUKResearch Florence Theberge Medical Research Council Janette Rawlinson Oxford Cancer PPI Françoise Howe #oxcode Chaired by Sarah Blagden   #oxcode24

How to get your research funded? We heard insights from our panel:

Talisia Quallo @CRUKResearch
Florence Theberge <a href="/The_MRC/">Medical Research Council</a>
Janette Rawlinson <a href="/OxfordCancer/">Oxford Cancer</a> PPI
<a href="/FrancoiseSHowe/">Françoise Howe</a> #oxcode

Chaired by <a href="/sarah_blagden/">Sarah Blagden</a>
 
#oxcode24
BBC Radio 4 Today (@bbcr4today) 's Twitter Profile Photo

"We now know that cancer does not come from nowhere." Prof Sarah Blagden, director of a new research collaboration between pharma giant GSK and the University of Oxford, tells #R4Today about the development of a new 'pre-cancer' vaccine that could target the disease earlier.